Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $195,000.00 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS) insider Michael Chi sold 7,500 shares of the stock in a transaction that occurred on Thursday, December 19th. The stock was sold at an average price of $26.00, for a total transaction of $195,000.00. Following the completion of the sale, the insider now owns 193,601 shares in the company, valued at $5,033,626. This represents a 3.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Michael Chi also recently made the following trade(s):

• On Tuesday, December 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The stock was sold at an average price of $32.25, for a total transaction of $234,102.75.
• On Monday, December 2nd, Michael Chi sold 2,054 shares of Hims & Hers Health stock. The shares were sold at an average price of $33.56, for a total value of $68,932.24.
• On Friday, October 25th, Michael Chi sold 17,304 shares of Hims & Hers Health stock. The stock was sold at an average price of $22.00, for a total value of $380,688.00.
• On Monday, October 21st, Michael Chi sold 7,500 shares of Hims & Hers Health stock. The shares were sold at an average price of $22.20, for a total value of $166,500.00.

Hims & Hers Health Price Performance

HIMS traded up $1.40 during midday trading on Monday, reaching $27.60. 10,968,314 shares of the company’s stock traded hands, compared to its average volume of 10,082,213. Hims & Hers Health, Inc. has a 52 week low of $8.09 and a 52 week high of $35.02. The firm has a fifty day moving average of $25.78 and a two-hundred day moving average of $21.26. The stock has a market capitalization of $6.03 billion, a price-to-earnings ratio of 62.73 and a beta of 1.25.

Hims & Hers Health (NYSE:HIMS) last announced its earnings results on Monday, November 4th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.26. The company had revenue of $401.56 million during the quarter, compared to the consensus estimate of $382.20 million. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The firm’s revenue for the quarter was up 77.1% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.04) earnings per share. Sell-side analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Analyst Ratings Changes

Several research firms recently weighed in on HIMS. Canaccord Genuity Group upped their price objective on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, December 2nd. Bank of America lowered shares of Hims & Hers Health from a “buy” rating to an “underperform” rating and decreased their price target for the stock from $32.00 to $18.00 in a report on Thursday, November 14th. TD Cowen reiterated a “buy” rating and issued a $28.00 price objective on shares of Hims & Hers Health in a report on Wednesday, November 20th. Morgan Stanley assumed coverage on Hims & Hers Health in a report on Tuesday, December 17th. They set an “overweight” rating and a $42.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $22.80.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of HIMS. Nisa Investment Advisors LLC boosted its position in shares of Hims & Hers Health by 679.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock worth $37,000 after purchasing an additional 1,603 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Hims & Hers Health by 67.5% during the second quarter. Bank of New York Mellon Corp now owns 678,602 shares of the company’s stock valued at $13,701,000 after buying an additional 273,473 shares during the last quarter. State of Michigan Retirement System boosted its holdings in Hims & Hers Health by 177.8% in the second quarter. State of Michigan Retirement System now owns 500,000 shares of the company’s stock worth $10,095,000 after acquiring an additional 320,000 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Hims & Hers Health by 322.9% during the second quarter. Allspring Global Investments Holdings LLC now owns 52,312 shares of the company’s stock valued at $1,056,000 after acquiring an additional 39,943 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Hims & Hers Health by 33.0% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,830 shares of the company’s stock worth $562,000 after purchasing an additional 6,912 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.